This article is publication 20 from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, which is registered with ClinicalTrials.gov (NCT00096733).
Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy
Article first published online: 11 MAR 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 19, Issue 3, pages 292–304, March 2013
How to Cite
Everson, G. T., Hoefs, J. C., Niemann, C. U., Olthoff, K. M., Dupuis, R., Lauriski, S., Herman, A., Milne, N., Gillespie, B. W., Goodrich, N. P. and Everhart, J. E. (2013), Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl, 19: 292–304. doi: 10.1002/lt.23592
In addition to the institutions affiliated with the authors, the Adult-to-Adult Living Donor Liver Transplantation Cohort Study includes Northwestern University (Chicago, IL), the University of California Los Angeles (Los Angeles, CA), Columbia University Health Sciences, NY, NY, University of Virginia, Charlottesville, VA, and Virginia Commonwealth University (Richmond, VA).
Gregory T. Everson and Claus U. Niemann were the principal investigators at the 2 clinical centers at the University of Colorado and the University of California San Francisco, respectively. John C. Hoefs and Norah Milne were responsible for the analyses of single-photon emission computed tomography liver-spleen scans. Kim M. Olthoff participated in the preparation of the manuscript. Robert Dupuis analyzed the erythromycin breath tests, and Shannon Lauriski analyzed the cholate clearances and shunt and the caffeine and galactose samples. Andrea Herman was the study coordinator in Colorado. Brenda W. Gillespie and Nathan P. Goodrich performed the statistical analyses. James E. Everhart was the project officer from National Institute of Diabetes and Digestive and Kidney Diseases.
Gregory T. Everson has intellectual property rights related to the filing (by the University of Colorado Denver) of US patent application 60/647,689 (Methods for Diagnosis and Intervention of Hepatic Disorders) on January 26, 2005 and International Application PCT/US2006/003132 as published under the Patent Cooperation Treaty, World Intellectual Property Organization, International Patent Classification A61K 49/00 (2006.01), International Publication Number WO 2006/081521 A2 on August 3, 2006. Everson also has an equity interest in HepQuant LLC. The other authors have no financial relationships to disclose.
This study was supported by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01-DK62536, U01-DK62444, U01-DK62467, U01-DK62483, U01-DK62484, U01-DK62494, U01-DK62496, U01-DK62498, U01-DK62505, and U01-DK62531) and by the University of California Irvine (contract 38643).
- Issue published online: 11 MAR 2013
- Article first published online: 11 MAR 2013
- Accepted manuscript online: 13 DEC 2012 04:58AM EST
- Manuscript Accepted: 6 NOV 2012
- Manuscript Received: 26 OCT 2012
This article has been cited by:
- 1Challenges in Living Donor Liver Transplantation, Clinics in Liver Disease, 2014, 18, 3, 651,